Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Shares Issued (2016 - 2025)

Anaptysbio (ANAB) has disclosed Shares Issued for 10 consecutive years, with $12.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 2100.36% year-over-year to $12.2 million, compared with a TTM value of $14.3 million through Dec 2025, up 446.61%, and an annual FY2025 reading of $14.3 million, up 120.32% over the prior year.
  • Shares Issued was $12.2 million for Q4 2025 at Anaptysbio, up from $336000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $12.2 million in Q4 2025 and bottomed at $160000.0 in Q3 2023.
  • Average Shares Issued over 5 years is $1.8 million, with a median of $811000.0 recorded in 2024.
  • The sharpest move saw Shares Issued skyrocketed 2800.6% in 2022, then tumbled 94.07% in 2023.
  • Year by year, Shares Issued stood at $1.6 million in 2021, then skyrocketed by 114.9% to $3.4 million in 2022, then plummeted by 92.28% to $264000.0 in 2023, then skyrocketed by 110.23% to $555000.0 in 2024, then surged by 2100.36% to $12.2 million in 2025.
  • Business Quant data shows Shares Issued for ANAB at $12.2 million in Q4 2025, $336000.0 in Q3 2025, and $1.4 million in Q2 2025.